Related Experiment Video

Updated: May 19, 2026

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
08:20

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol

Published on: December 30, 2016

Lineage-specific growth inhibition of NK cell lines by FOXO3 in association with Akt activation status

Kennosuke Karube1, Shinobu Tsuzuki, Noriaki Yoshida

  • 1Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.

Experimental Hematology
|August 28, 2012
PubMed

Insights

Forkhead box O3 (FOXO3) gene therapy shows promise for natural killer (NK) cell neoplasms. Unlike PRDM1, FOXO3 specifically suppresses NK cell proliferation, offering targeted treatment potential.

Area of Science:

  • Molecular Biology
  • Cancer Genetics
  • Immunology

Background:

  • The 6q21 chromosomal region, frequently deleted in natural killer (NK) cell neoplasms, harbors the FOXO3 and PRDM1 genes.
  • Previous studies indicated that forced expression of FOXO3 or PRDM1 inhibits proliferation in NK cell lines with 6q deletions.

Purpose of the Study:

  • To investigate the suppressive effects of forced FOXO3 and PRDM1 expression across various cell lineages.
  • To elucidate the mechanism behind the lineage-specific suppressive activity of FOXO3.

Main Methods:

  • Forced expression of FOXO3 and PRDM1 in diverse cell lines.
  • Analysis of FOXO3 subcellular localization (nuclear vs. cytoplasmic).
  • Assessment of Akt kinase activity in different cell types.

Main Results:

  • Forced PRDM1 expression suppressed proliferation in both NK and non-NK cell lines.
  • Forced FOXO3 expression selectively inhibited proliferation only in NK cell lines.
  • FOXO3 localized to the nucleus in NK cells but the cytoplasm in non-NK cells, correlating with lower Akt activity in NK cells.

Conclusions:

  • FOXO3 exhibits functional lineage specificity, selectively suppressing NK cell proliferation.
  • Low Akt activity in NK cells facilitates nuclear localization of FOXO3, leading to NK cell-specific effects.
  • FOXO3 presents a potential candidate for NK cell-specific gene therapy with minimized off-target effects.

More Related Videos

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro10:36

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro

Published on: January 9, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...